Represented CBC Group in closing second healthcare royalty fund (approximately $500 million)
Advised CBC Group in the formation of its fifth USD healthcare fund (US$1.67 billion)
Advised Orchid Asia Group in the formation of Fund VIII (US$1.35 billion)
Advised TPP in the formation of Fund II (over US$2.5 billion)
Advised LYFE Capital in the formation of Fund IV and III (over US$1.55 billion)
Advised LAV in the formation of Fund VII, Fund VI and Fund V
Advised Hosen Capital in the formation of Fund III (US$800 million)
Advised Jeneration Capital in the formation of Fund II (US$650 million)
Advised Ocean Link in the formation of Fund II (US$580 million)
Represented Kinzon Capital in GP-led RMB to USD redenomination transaction (approx. US$80 million)
Represented Bright VC in GP-led RMB to USD redenomination and stapled transaction
Represented Cathay Life Insurance in multiple LP portfolio transactions
Representing Asia-based sovereign wealth funds and several insurance companies in numerous investments in various private funds and SMAs
